Know Cancer

or
forgot password

Breath Test Assay for the Adjunctive Detection of Lung Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Lung Neoplasms

Thank you

Trial Information

Breath Test Assay for the Adjunctive Detection of Lung Cancer


This is a multicenter study comparing several groups of subjects with and without lung
cancer by CT scan, biopsy and the breath test. The breath test will be performed to validate
the methodology and the predictive algorithm that were previously developed.

Inclusion Criteria


Group 1 - Asymptomatic High Risk Subjects

Inclusion criteria

1. Patient is willing and able to cooperate with study and give signed informed consent
to participate.

2. Patient has had (or will have) chest imaging with spiral CT within 7 days of breath
test.

3. Age at least 18 years.

4. History of at least 10 pack-years of cigarette smoking.

5. Provide written informed consent prior to admission into the study.

Exclusion criteria

1. Previously documented history of cancer of any site.

Group 2 - Symptomatic High Risk Subjects Without a Tissue Diagnosis

Inclusion criteria

1. Patient is willing and able to cooperate with study and give signed informed consent
to participate.

2. Patient does not have a tissue diagnosis of pulmonary disease.

3. Patient is undergoing evaluation for an unexplained pulmonary illness which is
clinically consistent with lung cancer. This includes patients with unexplained
symptoms (e.g. chronic unexplained cough or hemoptysis), unexplained signs (e.g.
weight loss, lymphadenopathy) or unexplained investigations (e.g. an abnormal chest
x-ray).

4. Actively smoking patients, as well as never smokers and former smokers are eligible
for the study so long as a complete smoking consumption history can be recorded.

Exclusion criteria

1. Previously documented history of cancer of any other site.

Group 3 - Symptomatic High Risk Subjects with a Tissue Diagnosis

Inclusion criteria

1. Patient is willing and able to cooperate with study and give signed informed consent
to participate.

2. Patient has a tissue diagnosis of a. lung cancer. or b. pulmonary disease other than
lung cancer e.g. sarcoidosis, COPD, or pulmonary infection.

3. A diagnosis of lung cancer is defined as cytologic or histologic confirmation of lung
cancer by bronchoscopic/thoracoscopic means, sputum cytology, percutaneous fine
needle aspiration biopsy. Patients may have either non-small cell lung cancer or
small cell lung cancer.

4. Breath VOC collection will be obtained prior to any invasive procedure e.g.
thoracotomy, mediastinoscopy or mediastinotomy.

5. Actively smoking patients, as well as never smokers and former smokers are eligible
for the study so long as a complete smoking consumption history can be recorded.

Exclusion criteria

1. Previously documented history of cancer of any other site.

Group 4 - Apparently healthy subjects

Inclusion criteria

1. Willingness to follow protocol requirements as evidenced by written, informed
consent.

2. Healthy, male or female subjects, ages 18 and older.

3. Subjects who are non smokers having no signs or symptoms of lung carcinoma

Exclusion Criteria

1. Any active ongoing medical problems.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Sensitivity and specificity of the breath test as compared to CT and pathology to support primary lung cancer diagnosis.

Outcome Time Frame:

30 days after completion.

Safety Issue:

No

Principal Investigator

Michael Phillips, MD, FACP

Investigator Role:

Principal Investigator

Investigator Affiliation:

Menssana Research, Inc.

Authority:

United States: Food and Drug Administration

Study ID:

M08-01

NCT ID:

NCT00639067

Start Date:

June 2008

Completion Date:

March 2012

Related Keywords:

  • Lung Neoplasms
  • Cancer of Lung
  • Cancer of the Lung
  • Lung Cancer
  • Neoplasms, Lung
  • Neoplasms, Pulmonary
  • Pulmonary Cancer
  • Pulmonary Neoplasms
  • Neoplasms
  • Lung Neoplasms

Name

Location

Swedish Cancer InstituteSeattle, Washington  98104
New York University Medical CenterNew York, New York  10016
MD Anderson Cancer CenterOrlando, Florida  32806
Christiana HospitalWilmington, Delaware